Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Rises By 72.3%

Coloplast A/S (OTCMKTS:CLPBY) saw a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 105,800 shares, a growth of 72.3% from the January 15th total of 61,400 shares. Based on an average daily volume of 551,700 shares, the short-interest ratio is presently 0.2 days.

Coloplast A/S Trading Up 0.2 %

OTCMKTS CLPBY traded up $0.02 during trading on Friday, hitting $11.22. The company’s stock had a trading volume of 76,038 shares, compared to its average volume of 231,318. The company has a debt-to-equity ratio of 0.92, a current ratio of 1.02 and a quick ratio of 0.66. Coloplast A/S has a fifty-two week low of $10.63 and a fifty-two week high of $14.34. The business’s 50 day simple moving average is $11.19 and its 200-day simple moving average is $12.46.

Coloplast A/S (OTCMKTS:CLPBY) last released its earnings results on Tuesday, February 4th. The company reported $0.07 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.01). Coloplast A/S had a return on equity of 28.60% and a net margin of 17.81%. On average, analysts anticipate that Coloplast A/S will post 0.31 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on CLPBY shares. UBS Group raised Coloplast A/S from a “strong sell” rating to a “hold” rating in a report on Wednesday, December 11th. Sanford C. Bernstein raised Coloplast A/S from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 28th. Finally, Hsbc Global Res raised Coloplast A/S from a “moderate sell” rating to a “hold” rating in a report on Monday, November 18th.

Coloplast A/S Company Profile

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.